REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Eminvest Pharmaceuticals SRL (Romania)

Main Activities: All Other Chemical Product and Preparation Manufacturing
Full name: Eminvest Pharmaceuticals SRL Profile Updated: November 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Eminvest Pharmaceuticals SRL is an enterprise in Romania, with the main office in Bucharest. It operates in the All Other Chemical Product and Preparation Manufacturing industry. The company was established on January 25, 2005. The total number of employees is currently 32 (2024). The latest financial highlights indicate a net sales revenue increase of 22.73% in 2024. Its’ total assets recorded a growth of 32.1%. Eminvest Pharmaceuticals SRL’s net profit margin increased by 4.47% in 2024.

Headquarters
Strada Stefan Stoica Nr. 22
Bucharest; Bucharest; Postal Code: 070000

Contact Details: Purchase the Eminvest Pharmaceuticals SRL report to view the information.

Website: http://lorin.mihaescu@eminvest.ro

Basic Information
Total Employees:
Purchase the Eminvest Pharmaceuticals SRL report to view the information.
Registered Capital:
Purchase the Eminvest Pharmaceuticals SRL report to view the information.
Financial Auditors:
Purchase the Eminvest Pharmaceuticals SRL report to view the information.
Incorporation Date:
January 25, 2005
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
33.3333%
Purchase this report to view the information.
33.3333%
Purchase this report to view the information.
33.3333%
Company Performance
Financial values in the chart are available after Eminvest Pharmaceuticals SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
22.73%▲
Total operating revenue
22.7%▲
Operating profit (EBIT)
66.31%▲
EBITDA
54.36%▲
Net Profit (Loss) for the Period
79.41%▲
Total assets
32.1%▲
Total equity
40.39%▲
Operating Profit Margin (ROS)
4.65%▲
Net Profit Margin
4.47%▲
Return on Equity (ROE)
11.96%▲
Quick Ratio
0.02%▲
Cash Ratio
0.32%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo